期刊文献+

长期雌激素替代治疗对血压及心肌IR和IRS-1表达的影响 被引量:1

Effects of long-term estrogen replacement treatment on the blood pressure and expression of IR and IRS-1 in myocardium
下载PDF
导出
摘要 目的:研究长期雌激素替代治疗对血压及心肌组织胰岛素受体(IR)和胰岛素受体底物 1(IRS 1)表 达水平的影响。方法:将50只雌性SD大鼠随机分成3组,构建假手术、去势(去卵巢)和雌激素替代3组动物模 型。手术前后,用尾套法测定大鼠的尾动脉收缩压,RT PCR方法检测大鼠心肌IR和IRS 1的表达。结果:去势组 血压[(118.75±2.77)mmHg]明显高于假手术组[(103.86±1.84)mmHg,P<0.05]和替代组[(107.83±3.24) mmHg,P<0.05]。去势组大鼠心肌IRS 1的相对表达量(1.2588±0.1045)显著低于假手术组(2.2089±0.0988, P<0.05)和替代组(1.9100±0.1230,P<0.05)。然而,替代组与假手术组间血压和IRS 1的表达无明显差异 (P>0.05)。假手术、去卵巢和替代组间心肌IR的表达差异无统计学意义(P>0.05)。结论:长期雌激素替代治 疗可降低血压、增加心肌细胞IRS 1的表达,从而一定程度上保护心血管。但血清雌激素水平对心肌细胞IR的表 达影响不明显。 Objective To determine the effects of long-term estrogen replacement treatment on blood pressure and expressions of insulin receptor (IR) and insulin receptor substrate-1 (IRS-1) in myocardium. Methods Fifty female SD rats were randomly divided into 3 groups. And then sham (n=16), ovariectomy (OVX, n=17), and estrogen replacement treatment group (OVX + E 2, n=17) were established. Systolic blood pressure of tail artery was determined by tail-cuff technique before the operation and on week 12 after the operation. The expressions of IR and IRS-1 were measured by RT-PCR in myocardium of SD rats. Results Blood pressure [(118.75± 2.77)mmHg] in OVX was significantly higher than that in the sham [(103.86±1.84)mmHg, P<0.05] and OVX+E 2 [(107.83± 3.24)mmHg,P<0.05] rats. Expression of IRS-1 in OVX group was significantly lower ( 1.2588± 0.1045)than that in the sham(2.2089±0.0988, P<0.05) and OVX+E 2 groups (1.9100± 0.1230,P<0.05). However, there was no difference on blood pressure and expression of IRS-1 between sham and OVX+E 2 groups (P>0.05). The difference of IR expression has no statistical significance among the 3 groups. Conclusion Long-term estrogen replacement treatment might protect cardiovascular system through decreasing the blood pressure and inducing the expression of IRS-1 in myocardium. However, plasma estrogen level doesn′t significantly influence the IR expression.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2005年第1期38-40,56,共4页 Journal of Central South University :Medical Science
基金 国家自然科学基金(30300137) 湖南省自然科学基金(01JJY017)
关键词 雌激素替代治疗 血压 胰岛素敏感性 胰岛素受体 胰岛素受体底物^-1 long-term estrogen replacement treatment blood pressure insulin sensitivity insulin receptor insulin receptor substrate-1
  • 相关文献

参考文献13

  • 1Shen BJ, Todaro JF, Niaura R, et al. Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome x[J]. Am J Epidemiol, 2003,157(8): 701-11.
  • 2Spencer CP, Godsland IF, Cooper AJ, et al. Effects of oral and transdermal 17 beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women[J]. Metabolism, 2000, 49(6): 742-750.
  • 3Rossouw JE,Anderson GL,Prentice RL,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initative randomized controlled trial[J]. J Am Med Assoc, 2002,288(3):321-333.
  • 4Liu ML, Xu X, Song HP,et al. Influence of ovariectomy and 17β-estradiol treatment on insulin sensitivity, lipid metabolism and post-ischemic cardiac function[J]. Inter J Cardiol,2004,75(3):485-493.
  • 5Rappelli A. Hypertension and obesity after the menopause[J]. J Hypertens,2002, 20 (suppl 2):S26-S28.
  • 6Kumagai S, Holmang A, Bjorntorp P. The effects of oestrogen and progesterone on insulin sensitivity in female rats[J]. Acta Physiol Scand, 1993, 149(1):91-97.
  • 7Preston RA, Alonso A, Panzitta D, et al. Additive effect of drospirenone/ 17-beta-estradiol in hypertensive postmenopausal women receiving enalapril[J]. Am J Hypertens, 2002, 15(9):816-822.
  • 8Reynolds LP,Arnold DR,Kraft KC,et al. Co-immunolocallzation of endothelial nitric oxide synthase(eNOS)and vascular endothelail growth factor(VEGF)in endometrial vasculature of estradiol-treated ovariectomized ewes[J].Bio Reprod,2000,62(suppl):342.
  • 9Beato M. Gene regulation by steroid hormone[J]. Cell, 1989, 56(3):335-344.
  • 10Morelli C, Garofalo C, Bartucci M, et al. Estrogen receptor-alpha regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells[J]. Oncogene, 2003, 22(26):4007-4016.

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部